Loxia Consulting
ActiveFrom the official registers: KBO 16 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Loxia Consulting has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €294,833 and a net result of €77,323. Equity has been growing by about 8.1% per year since 2018. Its solvency ranks better than 84% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 07-04-2010 Normal situation
- Activity
- Research and development on biotechnology NACE 72101and 5 others
- Establishment unit
- 2.187.018.814 1170 Watermaal-Bosvoorde, since 22-04-2010
- Financial year end
- 31 December
- Peppol
- Reachable
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €118,036
- ▲ 303%
- Turnover
- ≈ €300,000
- estimated
- Profit
- €77,323
- ▲ 303%
- Equity
- €294,833
- ▲ 35.5%
- Total assets
- €325,836
- ▲ 39.4%
Score breakdownlowers riskLiquidity: current ratio 10.51, cash €313,037Equity €294,833 (90.5% of total assets)Size: total assets €325,836Sector: Scientific research and development (NACE 72)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 96% on liquidity, 78% on profitability and 84% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 53 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Result rose in 2025from €19,188 to €77,323 ▲ 303% View
- Positive: Higher solvency than 83% of companies in research and developmentsector median 60.5% · 615 companies 90.5% View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
- Positive: 8 profitable years in a rowprofit 2025: €77,323 8 years View
Comparable companies
These companies have the same main activity as Loxia Consulting: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €315,000 and €419,000, founded between 2010 and 2011.
| Company | Total assets | Gross margin |
|---|---|---|
| Loxia Consulting Watermaal-Bosvoorde | €325,836 | €118,036 |
| DOKTER BAMELIS MIA, DERMATOLOOG Aalst | €350,356 | €100,598 |
| IPM IMPACT Hasselt | €315,364 | €157,965 |
| MDTrials Brugge | €372,427 | €89,108 |
| LACTO RESEARCH Gembloux | €360,033 | €166,563 |
| Oblita Therapeutics Zoersel | €418,521 | €112,473 |
| Cabinet de Médecine Générale André Hotermans Stoumont | €364,240 | €71,258 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 27-05-2026
- Annual accounts 2024filed on 08-05-2025
- Annual accounts 2023filed on 05-06-2024
- Annual accounts 2022filed on 22-05-2023
Acts in the Belgian Official Gazette
All publications in the Belgian Official GazetteArticles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Loxia Consulting
- What is the company number of Loxia Consulting?
- The company number of Loxia Consulting is 0824.726.761. The VAT number is the same number with BE in front: BE 0824.726.761.
- Where is Loxia Consulting based?
- The registered office is at Kruisboogsquare 8, 1170 Watermaal-Bosvoorde.Company details
- What does Loxia Consulting do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of Loxia Consulting?
- The legal form of Loxia Consulting is Private limited company (pre-2019) (BVBA).
- When was Loxia Consulting founded?
- Loxia Consulting was founded on 07-04-2010.
- Is Loxia Consulting still active?
- Yes, Loxia Consulting is an active enterprise in the KBO register.
- What is the turnover of Loxia Consulting?
- The turnover in financial year 2025 is ≈ €300,000. This figure is estimated from the gross margin of €118,036 and 2,213 comparable companies of the same size. It probably lies between €200,000 and €460,000. It is a rough estimate.Financials
- Is Loxia Consulting profitable?
- In financial year 2025, Loxia Consulting made a profit of €77,323.
- Where can I find the annual accounts of Loxia Consulting?
- Loxia Consulting filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of Loxia Consulting due?
- Loxia Consulting must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.